HALE DAVID F - 31 Dec 2021 Form 5 Insider Report for Oncternal Therapeutics, Inc.

Role
Director
Signature
/s/Chase C. Leavitt, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
31 Dec 2021
Net transactions value
$0
Form type
5
Filing time
11 Feb 2022, 17:00:21 UTC
Previous filing
10 Dec 2021
Next filing
05 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONCT Common Stock Gift $0 -125,000 -18% $0.000000 588,152 01 Oct 2021 By Hale BioPharma Ventures, LLC
holding ONCT Common Stock 18,346 31 Dec 2021 By Hale Trading Company
* An asterisk sign (*) next to the price indicates that the price is likely invalid.